Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReFacto in Hemophilia A Surgery
NCT00092976Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of moroctocog alfa in hemophilia A, sponsored by Pfizer. Started Feb 2003; status: completed.
02
Drugs
moroctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00092976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092976.